Global Blood Therapeutics, Inc.
Global Blood Therapeutics, Inc. (GBT) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · GBT · as of Jun 9, 2026
Key Statistics
Explore Global Blood Therapeutics, Inc. Data
gbt stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 29 · Buy rate: 62.1%
The GBT analyst consensus is Buy, based on ratings from 29 Wall Street analysts over the past 3 months. The average 12-month price target is $60.38, representing -11.84% downside from the current price of $68.49.
Competitors & Peers
gbt competitorsGBT
ALPN
CBAY
ISEE
MOR
MORFStock Performance
Full HistoryAbout Global Blood Therapeutics, Inc.
Global Blood Therapeutics, Inc. (GBT) is a biopharmaceutical firm dedicated to discovering, developing, and providing therapies for patients suffering from sickle cell disease (SCD) who currently lack…
what is global blood therapeutics, inc. · gbt stock overview · global blood therapeutics, inc. company profile · who is global blood therapeutics, inc. ceo · gbt NASDAQ · global blood therapeutics, inc. headquarters · global blood therapeutics, inc. business segments
About Stock Overview & Key Data
Global Blood Therapeutics, Inc. (GBT) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Aug 12, 2015. As of the latest trading session, GBT stock price is $68.49, with a market capitalization of $0. The stock has returned +124.93% over the past 12 months and +0.00% year-to-date.
According to 29 Wall Street analysts, the consensus rating for Global Blood Therapeutics, Inc. stock is Buy, with an average 12-month price target of $60.38. In fiscal year 2021, Global Blood Therapeutics, Inc. reported revenue of $194.7M and net income of -$303.1M. For detailed data — including Global Blood Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Global Blood Therapeutics, Inc. (GBT) stock price is $68.49. The stock is traded on NASDAQ under the ticker symbol GBT. The 52-week range is $21.65 – $73.02.